FDA Approves Moderna’s mRNA RSV Vaccine — With No Input From Independent Advisers
The FDA said it bypassed input from the agency’s independent advisers because it didn’t see any “concerns or controversial issues.” Moderna is running at least 11 clinical trials for its new mRNA RSV drug on other demographic groups, including young children, adolescents and healthy adults. by Brenda Baletti, Ph.D. This article was originally published by The […]
FDA Approves Moderna’s mRNA RSV Vaccine — With No Input From Independent Advisers Read More »